Women over 50 are being diagnosed with sleep apnea at record rates because doctors spent decades treating it as a male condition

Women over 50 are being diagnosed with sleep apnea at record rates because doctors spent decades treating it as a male condition
Add DMNews to your Google News feed.
  • Tension: Women over 50 are receiving sleep apnea diagnoses at unprecedented rates — not because the condition is new, but because the medical system spent decades defining it by how it looks in men and dismissing women’s symptoms as menopause or aging.
  • Noise: The screening tools, clinical profiles, and diagnostic criteria for sleep apnea were built around male presentations — loud snoring, witnessed apneas, specific body types — causing women whose symptoms appeared as fatigue, insomnia, headaches, and brain fog to be chronically misdiagnosed for years.
  • Direct Message: The surge in diagnoses isn’t a triumph — it’s a correction that reveals decades of unnecessary suffering by women who were allowed to believe their exhaustion, cognitive decline, and deteriorating health were just what aging felt like.

To learn more about our editorial approach, explore The Direct Message methodology.

Linda Garza, a 54-year-old school librarian in Tucson, told her doctor she was exhausted. Not regular exhausted — the kind where you sit in your car after work for twenty minutes because walking to the front door feels like too much. Her doctor ran a thyroid panel. Normal. Checked her iron. Fine. Asked if she was feeling depressed. She said she didn’t think so, but honestly, she was too tired to know. He prescribed an antidepressant and told her to try walking thirty minutes a day.

It took three more years — three years of waking up with headaches, three years of her husband sleeping in the guest room because of her restless nights, three years of brain fog so thick she once forgot the name of a student she’d known since kindergarten — before a new physician asked a single question nobody had thought to ask: “Has anyone ever told you that you stop breathing in your sleep?”

Linda had severe obstructive sleep apnea. Her oxygen levels were dropping dozens of times per hour. And the reason nobody caught it for three years is painfully simple: she didn’t look like what doctors were trained to recognize.

She wasn’t an overweight man who snored like a freight train. She was a woman over 50 whose symptoms showed up as fatigue, insomnia, mood changes, and morning headaches — a presentation that medicine, for decades, essentially filed under “menopause” or “stress” or “depression” and moved on.

Linda’s story isn’t unusual. It’s becoming the norm. Women over 50 are now being diagnosed with sleep apnea at rates that would have seemed impossible twenty years ago — not because there’s a sudden epidemic, but because the medical establishment is finally confronting a diagnostic blind spot it created and maintained for the better part of forty years.

woman exhausted morning
Photo by Letícia Alvares on Pexels

Sleep apnea research has been male-dominated since its earliest clinical descriptions. The landmark studies that defined the condition — the Wisconsin Sleep Cohort Study in 1993, for instance — found ratios of male-to-female prevalence around 3:1 or even higher. Those numbers shaped everything: the screening questionnaires, the clinical profiles taught in medical schools, even the physical exam checklists. A 2013 review in the journal Sleep Medicine Reviews found that women with sleep apnea were systematically underdiagnosed because the disorder’s “classic” presentation — loud snoring, witnessed apneas, obesity concentrated in the neck and abdomen — was essentially a description of the male phenotype.

The female phenotype looks different. And nobody was looking for it.

Dr. Grace Yoon, a pulmonologist in Portland, Oregon, describes it this way: “A man comes in and says, ‘My wife says I stop breathing at night.’ A woman comes in and says, ‘I can’t sleep, I’m anxious, I wake up with headaches, and I’m gaining weight.’ Those two patients have the same disease. But one gets a sleep study, and the other gets a prescription for Ambien.”

The consequences of this aren’t abstract. Untreated sleep apnea increases risk of hypertension, stroke, heart failure, type 2 diabetes, and cognitive decline. A large-scale analysis published in Sleep found that women with untreated obstructive sleep apnea had a significantly elevated risk of cardiovascular events — in some age groups, even higher than their male counterparts, partly because by the time women got diagnosed, the condition had been silently damaging their cardiovascular system for years longer.

Years. That word keeps coming up.

Catherine Osei, 61, a retired nurse in Baltimore, was diagnosed at 58 after what she estimates was at least a decade of unrecognized symptoms. “I thought it was aging,” she told me. “I thought feeling this tired at 50 was just what happened. My mother was tired. My aunts were tired. We just thought that’s what being a woman past a certain age meant.” As we recently explored, doctors have spent decades looking for the wrong symptoms in women — and the consequences have compounded silently.

There’s a cruel irony embedded in the timeline. Menopause itself is a risk factor for sleep apnea. The decline in progesterone and estrogen — hormones that help maintain upper airway muscle tone — makes post-menopausal women significantly more vulnerable to airway collapse during sleep. So the very population most at risk was the one least likely to be screened, because the symptoms of their apnea overlapped almost perfectly with the symptoms their doctors attributed to menopause.

Fatigue? Menopause. Insomnia? Menopause. Mood disturbances? Menopause. Weight gain? Menopause. Morning headaches? Maybe menopause, maybe stress, here’s some ibuprofen.

sleep study equipment
Photo by Los Muertos Crew on Pexels

The pattern is familiar if you’ve been paying attention to how medicine treats women’s health complaints generally. It mirrors what happens with cardiac symptoms in women, with autoimmune conditions, with pain management. There’s a diagnostic template built around male bodies, and when women’s symptoms don’t match the template, the system doesn’t question the template — it questions the patient.

Marcus Delgado, a 47-year-old sleep technician in Chicago, sees the shift happening in real time. “Five years ago, maybe ten percent of our sleep study referrals were women over 50. Now it’s closer to thirty-five percent. And it’s not because more women suddenly developed apnea. It’s because someone finally started asking them the right questions.” He paused. “Or honestly, it’s because women started advocating for themselves after reading about it online, and doctors couldn’t keep dismissing them.”

That self-advocacy piece is significant — and complicated. It connects to something larger about how people, especially women in midlife, navigate a healthcare system that often minimizes their concerns. As a recent piece on this site explored, the people most accustomed to taking care of everyone else are often the worst at demanding care for themselves. Catherine told me she almost didn’t push for the sleep study. “I felt like I was being dramatic. My doctor had already told me everything was normal. Who was I to argue?”

She argued anyway. Her apnea-hypopnea index came back at 38 events per hour — severe. She’d been living in a state of chronic oxygen deprivation for what was likely over a decade.

The screening tools are also part of the problem. The most widely used questionnaire for sleep apnea risk — the STOP-Bang — was validated primarily on male surgical populations. Its questions emphasize snoring loudness, observed apneas, and BMI thresholds that don’t account for how women carry weight differently or how their apneas tend to be shorter, more frequent during REM sleep, and less likely to be witnessed because women are more likely to sleep alone after a certain age or because their bed partners are heavier sleepers.

Dr. Yoon again: “We built a net designed to catch large fish and then concluded that small fish didn’t exist.”

There’s a cognitive dimension, too, that deserves attention. As we’ve covered in reporting on brain health and cognitive decline, the things people attribute to normal aging — forgetfulness, difficulty concentrating, mental slowness — sometimes have treatable, reversible causes. Untreated sleep apnea is one of the most significant. Women in their 50s and 60s who assume their brain fog is just “getting older” may be experiencing the direct neurological effects of chronic intermittent hypoxia — and that distinction matters enormously, because one is inevitable and the other is fixable.

Naomi Watts recently spoke publicly about her menopause journey, and the broader cultural conversation around midlife women’s health has shifted meaningfully in the last few years. But awareness and systemic change are different things. The diagnostic criteria haven’t been rewritten. Many primary care physicians still don’t screen women for sleep apnea routinely. Insurance companies still sometimes require documented snoring — a symptom women report at far lower rates — before approving a sleep study.

The surge in diagnoses we’re seeing now isn’t a triumph. It’s a correction. And like all corrections, it reveals the scope of what was missed.

Renee Watkins, 52, a graphic designer in Minneapolis, was diagnosed six months ago. She’s been on CPAP therapy since, and she described the change to me in a way that stopped me cold. “I didn’t know I wasn’t thinking clearly until I started thinking clearly again. It was like someone cleaned a window I didn’t know was dirty. And then I got angry. Because I spent five years thinking I was losing myself — thinking maybe I was getting early dementia, maybe I was depressed, maybe this was just what my life looked like now. And it was oxygen. It was just oxygen.”

That grief — the grief of realizing you suffered unnecessarily, that the system designed to help you was looking the wrong way — has a weight to it. It echoes what others have described when discovering that a struggle they internalized as personal failure was actually a structural problem with a solution that existed all along.

Renee didn’t fail herself. Linda didn’t fail herself. Catherine didn’t fail herself. A system failed them by building its understanding of a common, dangerous condition around only half the population, and then spending decades not noticing.

The window is cleaner now. But a lot of women are still standing on the other side of the dirty glass, tired in a way they can’t explain, wondering if this is just what fifty feels like. It isn’t. And the fact that so many were allowed to believe it was — that’s not a medical footnote. That’s the whole story.

Feature image by RDNE Stock project on Pexels

Picture of Maya Torres

Maya Torres

Maya Torres is a lifestyle writer and wellness researcher who covers the hidden patterns shaping how we live, work, and age. From financial psychology to health habits to the small daily choices that compound over decades, Maya's writing helps readers see their own lives more clearly. Her work has been featured across digital publications focused on personal development and conscious living.

MOST RECENT ARTICLES

Researchers say the biggest factor in trauma survival isn't better doctors or better equipment — it's whether the team has worked together before

Researchers say the biggest factor in trauma survival isn’t better doctors or better equipment — it’s whether the team has worked together before

Technical SEO agencies promise rankings, but who’s auditing the auditors

Children with Dravet syndrome went from hundreds of seizures a day to a handful a week after receiving a new genetic treatment called zorevunersen

Children with Dravet syndrome went from hundreds of seizures a day to a handful a week after receiving a new genetic treatment called zorevunersen

A new Nature Aging study shows blood tests can detect two forms of dementia with up to 96% accuracy in genetically diverse populations most research ignores

A new Nature Aging study shows blood tests can detect two forms of dementia with up to 96% accuracy in genetically diverse populations most research ignores

Standard therapy for depression and anxiety is failing most autistic adults, major study of 7,175 patients finds

Standard therapy for depression and anxiety is failing most autistic adults, major study of 7,175 patients finds

Researchers say GLP-1 drugs like Ozempic are reducing cravings across alcohol, opioids, cocaine, and nicotine — and nothing in medicine has done that before

Researchers say GLP-1 drugs like Ozempic are reducing cravings across alcohol, opioids, cocaine, and nicotine — and nothing in medicine has done that before